|
|
|
The World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants)
11/1/2011 | published by: Kalorama Information
Arthritis is one of the most common human ailments worldwide. Arthritis is a complex family of musculoskeletal disorders with many causes that are not fully understood. The most crippling of the arthritis family is rheumatoid
|
more...
|
$3,500.00
|
|
Arthritis - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
Arthritis - Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Arthritis - Pipeline Review, H1 2012', provides an overview of the Arthritis therapeutic pipeline. This report provides information on the therapeutic development for Arthritis, complete with latest
|
more...
|
$500.00
|
|
Rheumatoid Arthritis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Rheumatoid Arthritis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Rheumatoid Arthritis - Pipeline Review, H1 2012', provides an overview of the Rheumatoid Arthritis therapeutic pipeline. This report provides information on the therapeutic development for Rheumatoid
|
more...
|
$500.00
|
|
Gouty Arthritis (Gout) – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Gouty Arthritis (Gout) – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Gouty Arthritis (Gout) - Pipeline Review, H1 2012', provides an overview of the Gouty Arthritis (Gout) therapeutic pipeline. This report provides information on the therapeutic
|
more...
|
$500.00
|
|
Arthritis Global Clinical Trials Review, H1, 2012
2/20/2012 | published by: GlobalData
Arthritis Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Arthritis Global Clinical Trials Review, H1, 2012 provides data on the Arthritis clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
11/30/2011 | published by: GlobalData
Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an
|
more...
|
$3,500.00
|
|
Osteoarthritis Pain – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Osteoarthritis Pain – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Osteoarthritis Pain - Pipeline Review, H1 2012', provides an overview of the Osteoarthritis Pain therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis
|
more...
|
$500.00
|
|
Psoriatic Arthritis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Psoriatic Arthritis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Psoriatic Arthritis - Pipeline Review, H1 2012', provides an overview of the Psoriatic Arthritis therapeutic pipeline. This report provides information on the therapeutic development for Psoriatic
|
more...
|
$500.00
|
|
Osteoarthritis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
Osteoarthritis – Pipeline Review, H1 2012 Summary Global Markets Direct’s, 'Osteoarthritis - Pipeline Review, H1 2012', provides an overview of the Osteoarthritis therapeutic pipeline. This report provides information on the therapeutic development for Osteoarthritis, complete with latest
|
more...
|
$500.00
|
|
Rheumatoid Arthritis Market Forecast
9/8/2011 | published by: Datamonitor
This interactive model includes 2010-20 patient-numbers and sales forecasts for traditional and biologic disease-modifying drugs in the seven major markets (the US, Japan, France, Germany, Italy, Spain and the UK). Introduction The launch of novel oral drugs
|
more...
|
$15,200.00
|
Related Markets
Arthritis Reports
- Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications
- Arthritis Global Clinical Trials Review, H1, 2012
- Osteoarthritis (OA) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- The World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants)
- Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate
